iuvo BioScience
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
iuvo BioScience - overview
Established
2015
Location
Rochester, NY, US
Primary Industry
Pharmaceuticals
About
Based in New York, US, and founded in 2015, iuvo BioScience, LLC, operates as a contract research organization (CRO). The firm was founded as Sterilization Testing Services (STS), which was acquired by Ethox International in 2002, which then was acquired by Moog, Inc. in 2009, and rebranded as MMC Sterilization Services Group, Inc. In March 2015, iovu was formed through the acquisition of the Life Science laboratory facility (MMDR, Inc.
) and MMC Sterilization Services Group, Inc business segments of Moog, Inc. In September 2022, Ampersand Capital Partners agreed to acquire the firm. iuvu as of October 2022, is led by its co-founders Ben Burton (President and CEO) and Mary Richardson (EVP and CSO), and chairman Daniel Spasic. The company provides preclinical testing services such as medical device testing, pharmaceutical testing, and ophthalmic testing, laboratory services, clinical research, development, and trial execution services, as well as scientific and regulatory consulting services to the small and midsized biotech and medical device industry globally.
Iuvo’s laboratory facility offers features for analytical chemistry, microbiology, pharmacology, and toxicology, and an on-site AAALAC-accredited vivarium along with offering sterilization validation services such as ethylene oxide sterilization, gamma, and E-beam. The September 2022 acquisition of the company will support the expansion of its integrated service portfolio and laboratory capacity.
Current Investors
Ampersand
Primary Industry
Pharmaceuticals
Sub Industries
Consulting Services, Pharmaceutical Research & Development
Website
www.iuvobioscience.com
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only
iuvo BioScience - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on, Corporate Carve Out, Trade Sale | Completed | iuvo BioScience's Lab Services and Consulting Businesses | - | ||||||||
| Add-on | Completed | Promedica International | - | ||||||||
| Buyout | Completed | iuvo BioScience | - |
Displaying 1 - 3 of 3
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.